Company: EHC
Filing Date: 2025-10-31
Form Type: 10-Q
Source: 0000785161-25-000115
Chunk: 43

Company: Encompass Health Corp
Filing Date: 2025-10-31
Form: 10-Q
Item: Part I, Item 1
Chunk 43
---
 — (23.6)— (23.6)Contribution of our hospital to consolidated joint venture— — 22.9 — — (30.8)(7.9)Other1.0 — (7.8)— 10.1 — 2.3 Balance at end of period100.8 $1.2 $1,838.2 $693.2 $(572.8)$709.3 $2,669.1 

The accompanying notes to condensed consolidated financial statements are an integral part of these condensed statements.5

Encompass Health Corporation and SubsidiariesCondensed Consolidated Statements of Cash Flows(Unaudited)

 Nine Months Ended September 30, 20252024 (In Millions)Cash flows from operating activities:  Net income$556.0 $432.4 Loss from discontinued operations, net of tax1.8 3.2 Adjustments to reconcile net income to net cash provided by operating activities—  Depreciation and amortization241.5 221.6 Stock-based compensation38.1 35.8 Deferred tax expense3.2 2.1 Other, net1.1 13.5 Change in assets and liabilities, net of acquisitions— Accounts receivable(18.8)29.1 Other assets(19.5)(43.3)Accounts payable(32.7)1.4 Accrued payroll6.4 (2.6)Accrued interest payable(15.8)(19.2)Other liabilities70.8 53.7 Net cash used in operating activities of discontinued operations(2.5)(3.7)Total adjustments271.8 288.4 Net cash provided by operating activities829.6 724.0 Cash flows from investing activities:Purchases of property, equipment, and intangible assets(507.1)(443.8)Proceeds from sale of restricted investments160.0 17.9 Purchases of restricted investments(165.9)(20.0)Other, net(12.2)(3.7)Net cash used in investing activities(525.2)(449.6)Cash flows from financing activities:Principal payments on debt, including pre-payments(113.2)(153.4)Principal borrowings on notes— 15.0 Borrowings on revolving credit